Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors

被引:27
作者
Sandalon, Z [1 ]
Bruckheimer, EM [1 ]
Lustig, KH [1 ]
Rogers, LC [1 ]
Peluso, RW [1 ]
Burstein, H [1 ]
机构
[1] Targeted Genet Corp, Seattle, WA 98101 USA
关键词
D O I
10.1128/JVI.78.22.12355-12365.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study evaluated and compared delivery of the tumor necrosis factor alpha receptor (TNFR)-immunoglobulin G1 (IgG1) Fc fusion (TNFR:Fc) gene to the lung by single and repeat administrations of multiple pseudotyped adeno-associated virus (AAV) vectors as a means for achieving systemic distribution of the soluble TNFR:Fc protein. A single endotracheal administration of AAV[2/5]cytomegalovirus (CMV)-TNFR:Fc vector (containing the AAV2 inverted terminal repeats and AAV5 capsid) to the rat lung resulted in long-term, high levels of serum TNFR:Fc protein that gradually declined over a period of 8 months. Endotracheal delivery of AAV[2/1]CMV-TNFR:Fc resulted in serum TNFR:Fc protein levels that were detectable for at least 4 months but were 10-fold lower than that of the AAV [2/5] vector. In contrast, secretion of the TNFR:Fc protein following pulmonary delivery of AAV[2/2]CMV-TNFR:Fc vector was very inefficient, and the protein was detected in the blood only when an airway epithelial cell-specific promoter, CC10, was substituted for the CMV enhancer/promoter to control transgene expression. In the context of AAV[2/5], the CC10 promoter was as efficient as CMV enhancer/promoter in generating similar levels of systemic TNFR:Fc protein, suggesting that this protein is secreted primarily from the airway epithelium. In mice, comparable long-term secretion of TNFR:Fc protein was demonstrated after AAV[2/2] and AAV[2/5] delivery, although the kinetics of transduction appeared to be different. All pseudotyped AAV vectors elicited serum anti-AAV capsid-neutralizing antibody responses, but these did not prevent lung transduction and efficient secretion of TNFR:Fc protein to the circulation following readministration with AAV[2/5]. These results highlight the potential utility of AAV vectors containing serotype 5 capsid to deliver and redeliver genes of secreted proteins to the lung to achieve long-term systemic protein expression.
引用
收藏
页码:12355 / 12365
页数:11
相关论文
共 54 条
[1]   Gene therapy restores vision in a canine model of childhood blindness [J].
Acland, GM ;
Aguirre, GD ;
Ray, J ;
Zhang, Q ;
Aleman, TS ;
Cideciyan, AV ;
Pearce-Kelling, SE ;
Anand, V ;
Zeng, Y ;
Maguire, AM ;
Jacobson, SG ;
Hauswirth, WW ;
Bennett, J .
NATURE GENETICS, 2001, 28 (01) :92-95
[2]   In vivo model of adeno-associated virus vector persistence and rescue [J].
Afione, SA ;
Conrad, CK ;
Kearns, WG ;
Chunduru, S ;
Adams, R ;
Reynolds, TC ;
Guggino, WB ;
Cutting, GR ;
Carter, BJ ;
Flotte, TR .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3235-3241
[3]   A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease [J].
Aitken, ML ;
Moss, RB ;
Waltz, DA ;
Dovey, ME ;
Tonelli, MR ;
McNamara, SC ;
Gibson, RL ;
Ramsey, BW ;
Carter, BJ ;
Reynolds, TC .
HUMAN GENE THERAPY, 2001, 12 (15) :1907-1916
[4]   Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins [J].
Auricchio, A ;
O'Connor, E ;
Weiner, D ;
Gao, GP ;
Hildinger, M ;
Wang, LL ;
Calcedo, R ;
Wilson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) :499-504
[5]   Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment [J].
Bantel-Schaal, U ;
Hub, B ;
Kartenbeck, J .
JOURNAL OF VIROLOGY, 2002, 76 (05) :2340-2349
[6]   Repeated delivery of adeno-associated virus vectors to the rabbit airway [J].
Beck, SE ;
Jones, LA ;
Chesnut, K ;
Walsh, SM ;
Reynolds, TC ;
Carter, BJ ;
Askin, FB ;
Flotte, TR ;
Guggino, WB .
JOURNAL OF VIROLOGY, 1999, 73 (11) :9446-9455
[7]   Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques [J].
Beck, SE ;
Laube, BL ;
Barberena, CI ;
Fischer, AC ;
Adams, RJ ;
Chesnut, K ;
Flotte, TR ;
Guggino, WB .
MOLECULAR THERAPY, 2002, 6 (04) :546-554
[8]  
Bennett J, 1997, INVEST OPHTH VIS SCI, V38, P2857
[9]   Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product [J].
Chan, JMK ;
Villarreal, G ;
Jin, WW ;
Stepan, T ;
Burstein, H ;
Wahl, SM .
MOLECULAR THERAPY, 2002, 6 (06) :727-736
[10]   Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors [J].
Chao, HJ ;
Liu, YB ;
Rabinowitz, J ;
Li, CW ;
Samulski, RJ ;
Walsh, CE .
MOLECULAR THERAPY, 2000, 2 (06) :619-623